Michael S Khodadoust, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khodadoust’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A118295 · Current
Licensed to practise in California · since 2011 · expires 2027-09-30 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$43,658
Medicare paid this office $43,658 for 91 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 55 | $23,126 | $126 |
| Return visit (30+ min) | 49 | $9,790 | $80 |
| New patient visit (60+ min) | 22 | $3,430 | $156 |
| Long return visit (40+ min) | 12 | $2,940 | $173 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 32 | $869 | $15 |
Who their Medicare patients are
91 Original Medicare patients in 2024. Average age 75 · Women 47% · Also on Medicaid 20% · Health risk score 2.27. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 65% · Diabetes 38% · Coronary heart disease 29% · Chronic kidney disease 29% · Atrial fibrillation 27% · Cancer 25% · Heart failure 23% · COPD 13% · Depression 12%.
The office billed $97,976, Medicare allowed $57,257 and paid $43,658; for 441 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 91 | 441 | 75 | 2.27 | $97,976 | $43,658 |
| 2023 | 82 | 358 | 74 | 2.45 | $82,977 | $41,097 |
| 2022 | 84 | 271 | 74 | 2.20 | $68,444 | $32,660 |
| 2021 | 94 | 319 | 74 | 2.13 | $71,367 | $35,735 |
| 2020 | 84 | 377 | 73 | 2.47 | $70,644 | $29,490 |
| 2019 | 107 | 472 | 72 | 2.19 | $77,159 | $39,504 |
| 2018 | 107 | 461 | 72 | 2.02 | $55,610 | $36,140 |
| 2017 | 62 | 316 | 73 | 2.18 | $54,235 | $22,106 |
| 2016 | 59 | 210 | 71 | 1.90 | $44,017 | $16,338 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 54 | $26,898 | $129 |
| Return visit (30+ min) | 48 | $9,033 | $89 |
| New patient visit (60+ min) | 17 | $2,839 | $167 |
| Short return visit (20+ min) | 12 | $915 | $61 |
2022: 3 services
| Long return visit (40+ min) | 61 | $24,014 | $126 |
| New patient visit (60+ min) | 24 | $3,831 | $160 |
| Return visit (30+ min) | 23 | $3,106 | $78 |
2021: 3 services
| Long return visit (40+ min) | 59 | $22,335 | $125 |
| Return visit (30+ min) | 42 | $7,469 | $82 |
| New patient visit (60+ min) | 17 | $2,922 | $172 |
2020: 4 services
| Return visit (30+ min) | 62 | $16,298 | $71 |
| Long return visit (40+ min) | 36 | $8,204 | $99 |
| New patient visit (60+ min) | 16 | $2,447 | $153 |
| Short return visit (20+ min) | 15 | $1,013 | $46 |
2019: 5 services
| Return visit (30+ min) | 55 | $15,902 | $69 |
| Long return visit (40+ min) | 40 | $10,501 | $96 |
| New patient visit (60+ min) | 23 | $3,503 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,924 | $94 |
| Short return visit (20+ min) | 21 | $1,489 | $44 |
2018: 4 services
| Return visit (30+ min) | 60 | $17,404 | $65 |
| Long return visit (40+ min) | 34 | $9,056 | $98 |
| New patient visit (60+ min) | 33 | $4,823 | $146 |
| Short return visit (20+ min) | 23 | $2,252 | $45 |
2017: 4 services
| Return visit (30+ min) | 31 | $9,981 | $69 |
| Long return visit (40+ min) | 29 | $5,354 | $92 |
| Short return visit (20+ min) | 26 | $3,697 | $46 |
| New patient visit (60+ min) | 17 | $2,389 | $141 |
2016: 4 services
| Return visit (30+ min) | 29 | $6,030 | $69 |
| Long return visit (40+ min) | 23 | $5,236 | $99 |
| New patient visit (60+ min) | 15 | $2,246 | $150 |
| Short return visit (20+ min) | 20 | $1,823 | $46 |
Drugs they prescribed that Part D paid
$86,023
Pharmacies billed $86,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
106 generic and fewer than 11 brand-name prescriptions · $86,023 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Famotidine | 13 | $70 | $5 |
| Prednisone | 14 | $65 | $5 |
| Ondansetron | 14 | $64 | $5 |
Year by year
| 2024 | 110 | 37 | None | None | $86,023 |
| 2023 | 108 | 32 | None | None | $445,633 |
| 2022 | 128 | 20 | None | 40% | $667,387 |
| 2021 | 98 | 21 | None | 16% | $145,147 |
| 2020 | 73 | 19 | None | 16% | $90,015 |
| 2019 | 71 | 22 | 0% (0) | 17% | $85,310 |
| 2018 | 106 | 17 | 0% (0) | None | $475,449 |
| 2017 | 111 | 16 | None | 37% | $429,850 |
| 2016 | 73 | 18 | None | 25% | $174,814 |
| 2015 | 15 | None | 0% (0) | None | $9,972 |
| 2014 | 18 | None | 0% (0) | None | $9,637 |
| 2013 | 35 | 18 | 69% (24) | None | $4,130 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Prednisone | 13 | $124 | $10 |
2022: 3 drugs
| Venclexta | 15 | $219,044 | $14,603 |
| Prednisone | 12 | $187 | $16 |
| Ondansetron | 18 | $166 | $9 |
2021: 1 drug
| Prednisone | 21 | $257 | $12 |
2020: 1 drug
| Gabapentin | 12 | $876 | $73 |
2018: 2 drugs
| Imbruvica | 14 | $177,727 | $12,695 |
| Acyclovir | 11 | $199 | $18 |
2017: 2 drugs
| Imbruvica | 24 | $359,350 | $14,973 |
| Famotidine | 11 | $101 | $9 |
2016: 1 drug
| Imbruvica | 11 | $150,443 | $13,677 |
Money from drug and device companies
$144 in 2025
| 2025 | 1 | 1 | None | $144 |
| 2021 | 1 | 1 | $1,455 | $1,455 |
| 2019 | 3 | 6 | $3,975 | $4,321 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Adcetris | $144 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-03-20 | Adcetris | $144 |
See earlier years (2021, 2019)
2021: $1,455
| Daiichi Sankyo | None | $1,455 | 1 payment
|
2019: $4,321
| Kyowa Kirin | Poteligeo | $2,676 | 3 payments
|
| Seattle Genetics | Adcetris | $1,625 | 2 payments
|
| Kite Pharma | Yescarta | $20 | 1 payment
|
Professional record
- NPI
- 1548573215
- Licence
- CA A118295California A118295: Current · expires 2027-09-30
- Trained
- University of Michigan Medical School, 2010
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Medical oncology (207RX0202X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-07-22
- NPI last updated
- 2026-08-25
- NPI record certified
- 2026-08-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 875 Blake Wilbur Dr, Palo Alto, CA, 94304